Sensei Biotherapeutics, Inc. - 10-K Filing
Sensei Biotherapeutics filed its Annual Report on Form 10-K for the year ended December 31, 2025. The report was certified by Christopher W. Gerry, President and General Counsel (Principal Executive Officer), and Josiah Craver, Senior Vice President, Finance (Principal Financial Officer).
Tickers: $SNSE